Trial Profile
A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2020
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Adenomyosis; Uterine cancer
- Focus Therapeutic Use
- 20 Jan 2020 Planned number of patients changed from 1128 to 380.
- 28 Jul 2018 Planned number of patients changed from 400 to 1128.
- 28 Jul 2018 Planned End Date changed from 30 Sep 2020 to 22 May 2021.